Companies / Santa Cruz Biotechnology / pan CEA (COL-1)
Santa Cruz Biotechnology

pan CEA (COL-1) | Santa Cruz Biotechnology

mouse monoclonal IgG2a; Carcinoembryonic antigen (CEA) is one of the most commonly used tumor markers in serum immunoassay determinations of carcinoma. Members of the CEACAM (carcinoembryonic antigen-related cell adhesion molecule) family contain a single N domain, with structural homology to the immunoglobulin variable domains, followed by a variable number of immunoglobulin constant-like A and/or B domains. CEACAMS, such as CEACAM1, CEACAM7, CD66C, CD66D and CD66E, have diverse roles within the cell, including roles in the differentiation and arrangement of tissue three-dimensional structure, angiogenesis, apoptosis, tumor suppression, metastasis, and the modulation of innate and adaptive immune responses. The human CEACAM proteins are encoded by genes which are located within a 1.2 Mb cluster on the long arm of chromosome 19.

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.